Search Results - "Larche, Mark, PhD" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma

Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma

by Kinoshita, Takashi, MD, Baatjes, Adrian, MSc, Smith, Steven G., PhD, Dua, Benny, MSc, Watson, Richard, BSc, Kawayama, Tomotaka, MD, Larche, Mark, PhD, Gauvreau, Gail M., PhD, O’Byrne, Paul M., MD, FRCPI
Published in Journal of allergy and clinical immunology (01.03.2014)

Get full text

Journal Article

1. Two Year Persistent Treatment Effect Achieved After 4 Doses of Cat-Peptide Antigen Desensitization (Cat-PAD) in an Environmental Exposure Chamber (EEC) Model of Cat Allergy

1. Two Year Persistent Treatment Effect Achieved After 4 Doses of Cat-Peptide Antigen Desensitization (Cat-PAD) in an Environmental Exposure Chamber (EEC) Model of Cat Allergy

by Hafner, Rod, PhD, Couroux, Peter, MD, Armstrong, Kristen, Patel, Deepen, Larche, Mark, PhD
Published in Journal of allergy and clinical immunology (01.02.2013)

Get full text

Journal Article

Safety and Tolerability of Fel d 1-Derived Peptide Antigen Desensitization in Subjects with Controlled Asthma

Safety and Tolerability of Fel d 1-Derived Peptide Antigen Desensitization in Subjects with Controlled Asthma

by Hickey, Pascal L.C., BPharm PhD, Cheema, Amarjit Singh, MD, Larche, Mark, PhD, Hafner, Rod, PhD
Published in Journal of allergy and clinical immunology (01.02.2013)

Get full text

Journal Article

An Update on Lymphocyte Subtypes in Asthma and Airway Disease

An Update on Lymphocyte Subtypes in Asthma and Airway Disease

by Moldaver, Daniel M, Larché, Mark, Rudulier, Christopher D
Published in Chest (01.05.2017)

Get more information

Journal Article

Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study

Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study

by Patel, Deepen, MD, Couroux, Peter, MD, Hickey, Pascal, PhD, Salapatek, Anne Marie, PhD, Laidler, Paul, PhD, Larché, Mark, PhD, Hafner, Roderick P., PhD
Published in Journal of allergy and clinical immunology (01.01.2013)

Get full text

Journal Article

Update on the current status of peptide immunotherapy

Update on the current status of peptide immunotherapy

by LARCHE, Mark
Published in Journal of allergy and clinical immunology (01.04.2007)

Get full text

Journal Article

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy

by Worm, Margitta, MD, Lee, Hae-Hyuk, MD, Kleine-Tebbe, Jörg, MD, Hafner, Roderick P., PhD, Laidler, Paul, PhD, Healey, David, MSc, Buhot, Cecile, PhD, Verhoef, Adrienne, PhD, Maillère, Bernard, PhD, Kay, A. Barry, MD, PhD, Larché, Mark, PhD
Published in Journal of allergy and clinical immunology (01.01.2011)

Get full text

Journal Article

Immune mechanisms of sublingual immunotherapy: Are oral Langerhans cells the masters of tolerance?

Immune mechanisms of sublingual immunotherapy: Are oral Langerhans cells the masters of tolerance?

by Larche, Mark
Published in Journal of allergy and clinical immunology (01.09.2010)

Get full text

Journal Article

Peptide and recombinant immunotherapy

Peptide and recombinant immunotherapy

by Larché, Mark
Published in Immunology and allergy clinics of North America (01.05.2011)

Get more information

Journal Article

Initial Evidence of Sustained Efficacy of House Dust Mite Synthetic Peptide Immuno Regulatory Epitopes 2 Years after a Short Course of Treatment in House Dust Mite (HDM) Allergic Subjects

Initial Evidence of Sustained Efficacy of House Dust Mite Synthetic Peptide Immuno Regulatory Epitopes 2 Years after a Short Course of Treatment in House Dust Mite (HDM) Allergic Subjects

by Hafner, Rod, PhD, Salapatek, AnneMarie, PhD, Larché, Mark, PhD, Ahenkorah, Brenda, Patel, Piyush, MD, FRCP, Pawsey, Stephen, MD
Published in Journal of allergy and clinical immunology (01.02.2015)

Get full text

Journal Article

Fel d 1 Peptide Immunotherapy Ameliorates Both Cat and Ovalbumin Responses, in a Dual Allergen Murine Model of Allergic Airways Disease

Fel d 1 Peptide Immunotherapy Ameliorates Both Cat and Ovalbumin Responses, in a Dual Allergen Murine Model of Allergic Airways Disease

by Moldaver, Daniel M, Bharhani, Mantej S, Rudulier, Christopher D., PhD, Wattie, Jennifer, Inman, Mark D., MD, PhD, Larché, Mark, PhD
Published in Journal of allergy and clinical immunology (01.02.2016)

Get full text

Journal Article

Persistent Treatment Effect with Grass Synthetic Peptide Immuno-Regulatory Epitopes in Grass Allergy Symptoms in an Environmental Exposure Unit Challenge after a Second Season of Natural Pollen Exposure

Persistent Treatment Effect with Grass Synthetic Peptide Immuno-Regulatory Epitopes in Grass Allergy Symptoms in an Environmental Exposure Unit Challenge after a Second Season of Natural Pollen Exposure

by Ellis, Anne, MD, MSc, FAAAAI, Frankish, Charles W., MD, Armstrong, Kristen, MSc, Larché, Mark, PhD, Steacy, Lisa, BSc, Hafner, Rod, PhD, O'Hehir, Robyn, FRACP, PhD, FRCP, FRCPath
Published in Journal of allergy and clinical immunology (01.02.2015)

Get full text

Journal Article

The Nasal Allergen Challenge Protocol of the Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): Validation in a Clinical Trial of Cat Synthetic Peptide Immunoregulatory Epitopes (Cat-SPIRE)

The Nasal Allergen Challenge Protocol of the Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): Validation in a Clinical Trial of Cat Synthetic Peptide Immunoregulatory Epitopes (Cat-SPIRE)

by Neighbour, Helen, Larché, Mark, PhD, Steacy, Lisa, BSc, Armstrong, Kristen, M.Sc, Hickey, Pascal L.C., PhD, Soliman, Mena, MBChB, Ellis, Anne, MD, MSc, FAAAAI
Published in Journal of allergy and clinical immunology (01.02.2015)

Get full text

Journal Article

Ara h 1 Peptide Immunotherapy Ameliorates Peanut-Induced Anaphylaxis

Ara h 1 Peptide Immunotherapy Ameliorates Peanut-Induced Anaphylaxis

by Simms, Elizabeth, MSc, Rudulier, Christopher, Wattie, Jennifer, Kwok, William W., PhD, James, Eddie A., PhD, Moldaver, Daniel M, Jordana, Manel, MD, PhD, Larché, Mark, PhD
Published in Journal of allergy and clinical immunology (01.02.2015)

Get full text

Journal Article

The Contribution of Peptide-MHC Affinity to the Efficacy of Peptide Immunotherapy in a Murine Model of Allergic Airways Disease

The Contribution of Peptide-MHC Affinity to the Efficacy of Peptide Immunotherapy in a Murine Model of Allergic Airways Disease

by Moldaver, Daniel M, Singh, Tarandeep, Babra, Melissa, Rudulier, Christopher, Bharhani, Mantej S, Wattie, Jennifer, van Hage, Marianne, MD, PhD, Inman, Mark D., MD, PhD, Larché, Mark, PhD
Published in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (01.02.2015)

Get full text

Journal Article Conference Proceeding

A Bell-Shaped Dose-Dependent Induction of Allergen-Specific Tetramer+ CD4 T Cells and Activated Lung ILC2s Following Epicutaneous Allergen Sensitization in HLA-DR4 Transgenic Mice

A Bell-Shaped Dose-Dependent Induction of Allergen-Specific Tetramer+ CD4 T Cells and Activated Lung ILC2s Following Epicutaneous Allergen Sensitization in HLA-DR4 Transgenic Mice

by Rudulier, Christopher D., PhD, Moldaver, Daniel M, Singh, Tarandeep, Nayve, Ivan, Wattie, Jennifer, van Hage, Marianne, MD, PhD, James, Eddie A., PhD, Kwok, William W., PhD, Larché, Mark, PhD
Published in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (01.02.2015)

Get full text

Journal Article Conference Proceeding